[  
   {  
      "id":"1",
      "description":"\"Harvard Pilgrim To Pay for 2 Autoimmune Drugs Based on Outcomes, Value\", Managed Care, 2017",
      "link":"http:\/\/www.managedcaremag.com\/dailynews\/20170223\/harvard-pilgrim-pay-2-autoimmune-drugs-based-outcomes-value",
      "date":"2018-07-25 11:20:31"
   },
   {  
      "id":"2",
      "description":"Outcomes-Based Pharmaceutical Contracts: An Answer to High U.S. Drug Spending? Commonwealth Fund Issue Brief, September 2017",
      "link":"http:\/\/www.imlcc.org\/",
      "date":"2018-07-25 11:22:21"
   },
   {  
      "id":"3",
      "description":"\"Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper\", Duke University, 2017",
      "link":"http:\/\/healthpolicy.duke.edu\/sites\/default\/files\/atoms\/files\/value_based_payment_background_paper_-_october_2017_final.pdf",
      "date":"2018-07-25 11:23:15"
   },
   {  
      "id":"4",
      "description":"\"Health Insurers Push to Tie Drug Prices to Outcomes\", The Wall Street Journal, 2016",
      "link":"http:\/\/www.akleg.gov\/basis\/Bill\/Text\/29?Hsid=SB0074Z",
      "date":"2018-07-25 11:23:37"
   },
   {  
      "id":"5",
      "description":"\"Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper\", Duke University, 2017; \"Harvard Pilgrim Signs Outcomes-Based Contracts with AstraZeneca for Brilinta and Bydureon\", BusinessWire (2017)",
      "link":"http:\/\/dhss.alaska.gov\/dph\/HealthPlanning\/Pages\/telehealth\/regsandstatutes.aspx",
      "date":"2018-07-25 11:23:49"
   },
   {  
      "id":"6",
      "description":"The U.S. OBIC Tracker, Stisali, updated May 2017",
      "link":"http:\/\/dhss.alaska.gov\/dph\/HealthPlanning\/Pages\/telehealth\/regsandstatutes.aspx",
      "date":"2018-07-25 11:24:02"
   },
   {  
      "id":"7",
      "description":"Alnylam Announces Alignment on Value-Based Agreements with Leading Health Insurers and Launches Comprehensive Patient Support Services for ONPATTRO (patisiran), Alnylam press release, August 2018",
      "link":"http:\/\/www.managedcaremag.com/dailynews/20170223/harvard-pilgrim-pay-2-autoimmune-drugs-based-outcomes-value",
      "date":"2018-07-25 11:24:02"
   },
  
   {  
      "id":"8",
      "description":"Performance-Based Risk-Sharing Arrangements for Pharmaceutical Products in the United States: A Systematic Review",
      "link":"https:\/\/medicaid.alabama.gov\/content\/Gated\/7.6.1G_Provider_Manuals\/7.6.1.1G_Jan2018\/Jan18_28.pdf",
      "date":"2018-07-25 11:24:35"
   },
   {  
      "id":"9",
      "description":"\"Overcoming Challenges of Outcomes-Based Contracting for Pharmaceuticals: Early Lessons from the Genentech - Priority Health Pilot\", Health Affairs Blog, 2017",
      "link":"https:\/\/legiscan.com\/AR\/text\/SB146\/2017",
      "date":"2018-07-25 11:24:52"
   },
   {  
      "id":"10",
      "description":"\"Aetna and Merck Sign a Unique Value-Based Contract to Januvia and Janumet\", Aetna Press Release, October 2016",
      "link":"https:\/\/legiscan.com\/AR\/text\/SB146\/2017",
      "date":"2018-07-25 11:25:10"
   },
   {  
      "id":"11",
      "description":"Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper, 2017",
      "link":"https:\/\/www.medicaid.state.ar.us\/Download\/provider\/provdocs\/Manuals\/PHYSICN\/PHYSICN_II.doc",
      "date":"2018-07-25 11:25:24"
   },
   {  
      "id":"12",
      "description":"Outcomes-Based Pharmaceutical Contracts: An Answer to High U.S. Drug Spending? Commonwealth Fund Issue Brief, September 2017",
      "link":"https:\/\/healthpolicy.duke.edu/sites/default/files/atoms/files/value_based_payment_background_paper_-_october_2017_final.pdf",
      "date":"2018-07-25 11:25:43"
   },
   {  
      "id":"13",
      "description":"Outcomes-Based Contracts Offer Payers New Pharmaceutical Options,HealthPayer Intelligence, 2018; Spark Therapeutics Press Release, Jan 2018",
      "link":"https:\/\/www.colorado.gov\/pacific\/sites\/default\/files\/CMS1500_Telemedicine%20v1_1.pdf",
      "date":"2018-07-25 11:25:54"
   }
   ,
   {  
      "id":"14",
      "description":"Expanding Access to a Hep C Cure, Express Scripts Press Release, December 2014",
      "link":"http:\/\/lab.express-scripts.com\/lab\/insights\/specialty-medications\/expanding-access-to-a-hep-c-cure",
      "date":"2018-07-25 11:25:54"
   }
   ,
   {  
      "id":"15",
      "description":"UPMC Health Plan Announces Agreement for VIVITROL, UPMC Health Plan Press Release, August 2018",
      "link":"https:\/\/www.upmchealthplan.com\/pdf\/ReleasePdf\/2018_08_30.html",
      "date":"2018-07-25 11:25:54"
   }
   
   ,
   {  
      "id":"16",
      "description":"Alnylam Announces Alignment on Value-Based Agreements with Leading Health Insurers and Launches Comprehensive Patient Support Services for ONPATTRO (patisiran), Alnylam press release, August 2018",
      "link":"http:\/\/investors.alnylam.com\/news-releases\/news-release-details\/alnylam-announces-alignment-value-based-agreements-leading",
      "date":"2018-07-25 11:25:54"
   }
   ,
   {  
      "id":"17",
      "description":"Best Candidates for PCSK9 Inhibitors, ManagedHealthcare Executive, 2016",
      "link":"http:\/\/www.managedhealthcareexecutive.com\/formulary\/best-candidates-pcsk9-inhibitors",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"18",
      "description":" Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper, Duke University, 2017; Harvard Pilgrim Signs Outcomes-Based Contracts with AstraZeneca for Brilinta and Bydureon, BusinessWire (2017)",
      "link":"https:\/\/healthpolicy.duke.edu\/sites\/default\/files\/atoms\/files\/value_based_payment_background_paper_-_october_2017_final.pdf",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"19",
      "description":"UPMC Health Plan, AstraZeneca Enter Into Value-Based Agreement for Heart Drug, AJMC, January 2019",
      "link":"https:\/\/www.ajmc.com\/newsroom\/upmc-health-plan-astrazeneca-enter-into-valuebased-agreement-for-heart-drug",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"20",
      "description":"The U.S. OBIC Tracker, Stisali, updated May 2017",
      "link":"https:\/\/www.slideshare.net\/NickMerryfield\/us-outcomes-based-innovative-contracting-tracker-may-31-2017",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"21",
      "description":"Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper, Duke University, 2017",
      "link":"https:\/\/healthpolicy.duke.edu\/sites\/default\/files\/atoms\/files\/value_based_payment_background_paper_-_october_2017_final.pdf",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"22",
      "description":"Pushing 'value', Harvard Pilgrim tests outcomes deals, BioPharmaDive, 2018",
      "link":"http:\/\/www.biopharmadive.com\/news\/harvard-pilgrim-astrazeneca-symbicort-value-contract\/521659\/",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"23",
      "description":"Highmark Health strikes outcomes-based contract for asthma drug, ModernHealthcare, April 2018",
      "link":"http:\/\/www.modernhealthcare.com\/article\/20180417\/NEWS\/180419931\/highmark-health-strikes-outcomes-based-contract-for-asthma-drug",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"24",
      "description":"Prime Therapeutics signs CareCentered Contract with leading manufacturer of Multiple Sclerosis Drug, PrimeTherapeutics Press Release December, 2017",
      "link":"http:\/\/www.primetherapeutics.com\/en\/news\/pressreleases\/2017\/ms-care-centered-contract-release.html",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"25",
      "description":"Highmark Inc. Announces Outcomes-Based Agreement with Boehringer Ingelheim for Jardiance, Highmark Press Release, 2018",
      "link":"http:\/\/www.highmark.com\/hmk2\/newsroom\/2018\/pr071018Boehringer.shtml",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"26",
      "description":"Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance, Prime Therapeutics Press Release, 2018",
      "link":"http:\/\/www.primetherapeutics.com\/en\/news\/pressreleases\/2018\/jardiance-carecenterecontract-release.html",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"27",
      "description":"UPMC Health Plan and Boehringer Ingelheim Announce Innovative Value-Based Agreement, Cision PR Newswire, September 2018",
      "link":"http:\/\/www.prnewswire.com\/news-releases\/upmc-health-plan-and-boehringer-ingelheim-announce-innovative-value-based-agreement-300720502.html",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"28",
      "description":"Cigna to End OxyContin painkiller coverage, signs contract for Alternative, Reuters Health News, October 2017",
      "link":"http:\/\/www.reuters.com\/article\/us-cigna-opioids-idUSKBN1C932L",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"29",
      "description":"Harvard Pilgrim Signs Value-Based Contract with Eli Lilly & Company for its Osteoporosis drug, Forteo, Metro Hartford Alliance , February 2017",
      "link":"http:\/\/www.metrohartford.com\/newsroom\/investor-news\/2017\/02\/24\/harvard-pilgrim-signs-value-based-contract-with-eli-lilly-company-for-its-osteoporosis-drug-forteo",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"30",
      "description":"Harvard Pilgrim Signs Value-Based Contract with Eli Lilly for Trulicity, Harvard Pilgrim Press Release, June 2016",
      "link":"http:\/\/www.harvardpilgrim.org\/public\/news-detail?nt=HPH_News_C&nid=1471911699289",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"31",
      "description":"Overcoming Challenges of Outcomes-Based Contracting for Pharmaceuticals: Early Lessons from the Genentech - Priority Health Pilot, Health Affairs Blog, 2017",
      "link":"http:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20170403.059442\/full\/",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"32",
      "description":"Cigna Signs Agreement with Gilead to Improve Affordability of Hepatitis C Treatment for Customers and Clients Cigna Press Release, 2015",
      "link":"http:\/\/www.cigna.com\/newsroom\/news-releases\/2015\/cigna-signs-agreement-with-gilead-to-improve-affordability-of-hepatitis-c-treatment-for-customers-and-clients",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"33",
      "description":"Prime Therapeutics inks value-based contract for Stelara with Janssen, Prime Therapeutics Press Release, Oct 2018",
      "link":"http:\/\/www.primetherapeutics.com\/en\/news\/pressreleases\/2018\/stelara-value-based-contract-release.html",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"34",
      "description":"Cigna and Merck Sign Performance-Based Contract, BusinesssWire, April 2019",
      "link":"http:\/\/www.businesswire.com/news/home/20090423005503/en/CIGNA-Merck-Sign-Performance-Based-Contract",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"35",
      "description":"Aetna and Merck Sign a Unique Value-Based Contract to Januvia and Janumet, Aetna Press Release, October 2016",
      "link":"http:\/\/investor.aetna.com\/phoenix.zhtml?c=110617&p=irol-newsArticle&ID=2210771",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"36",
      "description":"Cigna and EMD Serono Team to Fight Multiple Sclerosis Under First Outcomes-Based Specialty Medication Contract, Cigna Press Release, 2011 ",
      "link":"http:\/\/www.cigna.com\/newsroom\/news-releases\/2011\/pdf\/cigna-and-emd-serono-team-to-fight-multiple-sclerosis-under-first-outcomes-based-specialty-medication-contract.pdf",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"37",
      "description":"Prime Therapeutics signs outcomes-based contract with Novo Nordisk for Type 2 Diabetes drug Victoza, Prime Therapeutics Press Release, December 2017",
      "link":"http:\/\/www.primetherapeutics.com\/en\/news\/pressreleases\/2017\/diabetes-care-centered-contract-release.html",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"38",
      "description":"SelectHealth Signs Value-based Contract with Novo Nordisk, Global News Wire, March 20187",
      "link":"http:\/\/www.globenewswire.com\/news-release\/2018\/03\/22\/1444516\/0\/en\/SelectHealth-Signs-Value-based-Contract-With-Novo-Nordisk.html",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"39",
      "description":"Health Insurers Push to Tie Drug Prices to Outcomes, The Wall Street Journal, 2016",
      "link":"http:\/\/www.wsj.com\/articles\/health-insurers-push-to-tie-drug-prices-to-outcomes-1462939262",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"40",
      "description":"Sanofi and Regeneron to lower net price of Praluent (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients, Sanofi Press release, May 2018",
      "link":"http:\/\/www.news.sanofi.us\/2018-05-01-Sanofi-and-Regeneron-to-lower-net-price-of-Praluent-R-alirocumab-Injection-in-exchange-for-straightforward-more-affordable-patient-access-for-Express-Scripts-patients",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"41",
      "description":"Outcomes-Based Contracts Offer Payers New Pharmaceutical Options,HealthPayer Intelligence, 2018",
      "link":"http:\/\/healthpayerintelligence.com\/news\/outcomes-based-contracts-offer-payers-new-pharmaceutical-options",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"42",
      "description":"Spark Therapeutics Announces First-of-their-kind Programs to Improve Patient  Access to LUXTURNA (voretigene neparvovec-rzyl), a One-time Gene Therapy Treatment, Spark Therapeutics Press Release, Jan 2018",
      "link":"http:\/\/ir.sparktx.com\/news-releases\/news-release-details\/spark-therapeutics-announces-first-their-kind-programs-improve",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"44",
      "description":"Harvard Pilgrim adds new drugs under 'pay-for-performance' deals, Boston Globe, June 2016",
      "link":"http:\/\/www2.bostonglobe.com\/business\/2016\/06\/27\/harvard-pilgrim-adds-new-drugs-under-pay-for-performance-deals\/2OQYId32R5RSc0s8wGKooM\/story.html",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"45",
      "description":"Outcomes-Based Pharmaceutical Contracts: An Answer to High U.S. Drug Spending? Commonwealth Fund Issue Brief, September 2017",
      "link":"http:\/\/www.commonwealthfund.org\/sites\/default\/files/documents\/___media_files_publications_issue_brief_2017_sep_seeley_outcomes_based_pharma_contracts_ib.pdf",
      "date":"2018-07-25 11:25:54"
   },
   {  
      "id":"46",
      "description":"In Historic First, FDA approves Novartis CAR-T Therapy, BiopharmaDive, August 2017",
      "link":"http:\/\/www.biopharmadive.com\/news\/novartis-cart-fda-approval-kymriah-gene-therapy\/503888\/",
      "date":"2018-07-25 11:25:54"
   }
   
  
   
   
  
   
   
  
   
   
   
   
   
   
  
]